icon
موقع حكومي رسمي تابع لحكومة المملكة العربية السعودية
icon الثلاثاء 9 جمادى الأولى 1448هـ
نسخة تجريبية
icon
روابط المواقع الالكترونية الرسمية السعودية تنتهي بـ gov.sa

جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa

icon
المواقع الرسمية الآمنة تستخدم HTTPS

تحقق من أن الموقع يستخدم بروتوكول HTTPS

icon

مسجل لدى هيئة الحكومة الرقمية برقم :

20250831619
اقتراحات

قائمة الدراسات السريرية المسجلة على الادوية

عرض 401 - 410 من 518
عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
Changing Diabetes® World Tour Novonordisk Ongoing N/A 4 version 6 - October 2010 King Abdulaziz University Hospital (Jeddah)
A Prospective Observational Study on the home treatment of haemarthrosis with VIIa (activated recombinant factor VII) in haemophilia A and B patient with inhibitors Novonordisk Ongoing NovoSeven (activated recombinant factor VII) 4 F7HEAM-3850 King Khalid University Hospital (Riyadh)
DISCOVER Study - Drug Treatment Reality of Type 2 Diabetes in Real World Settings Internationally -D1690R00002 AstraZeneca Ongoing N/A 4 D1690R0000 King Fahad Medical City (Riyadh), Aseer Central Hospital, King Salman Bin AbdulAziz Hospital (Riyadh), Prince Mutaib Bin Abdul Aziz Hospital (Sakaka), King Khalid University Hospital (Riyadh), Armed Forces Hospital (khamis mushait), King Abdulaziz Hospital and Oncology Center (Jeddah), King Fahad Hospital (Jeddah)
Saudi rEgistry of Cardiovascular Risk factor managEmenT in HemoDialysis patients Sanofi Ongoing N/A 4 2 King Abdulaziz University Hospital (Jeddah), King Fahad Hospital (Jeddah), King Khalid General Hospital (Hail), King Abdulaziz University Hospital (Jeddah), Al-Noor Specialist Hospital (Makkah), Dr. Soliman Fakeeh Hospital (Jeddah), King Salman Kidney Diseases Center (Riyadh)
A multicenter, observational, phase IV study of the use of Pregabalin (Nervax®) on adult patients for the management of Neuropathic pain in Saudi Arabia Tabuk Pharmaceuticals Ongoing NERVAX 4 N-001 King Fahad Medical City (Riyadh)
A multicenter, observational, prospective study of the use of Diclofenac Sodium 75 mg Dual Release Capsules (Divido®) on adult patients with persistent or chronic pain and inflammation in Saudi Arabia Tabuk Pharmaceuticals Ongoing Divido 4 D-001 King Fahad Medical City (Riyadh)
Multinational, Prospective, Observational Study to Assess the Unmet Medical Needs associated with Basal Insulin Use in Patients with Type 2 Diabetes Newly or Recently Initiated with Basal Insulin Treatment Sanofi Ongoing N/A 4 OBS13780 King Khalid University Hospital (Riyadh)
Evaluation of Asthma Management in Middle EAst North Africa Adult population ( ESMAA Study ) AstraZeneca Ongoing N/A 4 RME-XXX-20 Soliman Fakeeh Hospital (Jeddah), King Abdulaziz Hospital and Oncology Center (Jeddah), Armed Forces Hospital (dhahran), King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), Armed Forces Hospital (Taif), King Fahad Specialist Hospital (Dammam), International Medical Center (Jeddah), King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
Verifying Insulin Strategy and Initial Health Outcome Analysi Eli Lilly Ongoing N/A 4 F3Z-MC-B01 International Medical Center (Jeddah), King Fahd University Hospital (al khobar), King Fahad Medical (City), Armed Forces Hospital (Taif)
The Effect of Vitamin D3 on Biomarkers of Glycaemia and Oxidative Stress in Saudi Men with Poorly-Controlled Type 2 Diabetes Mellitus King Fahad Medical City Ongoing Vitamin D Capsules 4 H-01-R-012 King Fahad Medical City (Riyadh)